oxonic acid has been researched along with Cancer of Nose in 4 studies
Oxonic Acid: Antagonist of urate oxidase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Yasumatsu, R | 1 |
Nakashima, T | 1 |
Sato, M | 1 |
Nakano, T | 1 |
Kogo, R | 1 |
Hashimoto, K | 1 |
Sawatsubashi, M | 1 |
Nakagawa, T | 1 |
Iguchi, H | 1 |
Uyama, T | 1 |
Kanazawa, A | 1 |
Amatsu, H | 1 |
Yamane, H | 1 |
Kusuki, M | 1 |
Nakamura, A | 1 |
Kajikawa, H | 1 |
Chatani, M | 1 |
Matsushiro, N | 1 |
Kamakura, T | 1 |
Kitamura, T | 1 |
Okumura, S | 1 |
Okano, S | 1 |
Tahara, M | 1 |
Zenda, S | 1 |
Fuse, N | 1 |
Yoshino, T | 1 |
Doi, T | 1 |
Kawashima, M | 1 |
Ogino, T | 1 |
Hayashi, R | 1 |
Ohtsu, A | 1 |
4 other studies available for oxonic acid and Cancer of Nose
Article | Year |
---|---|
Clinical management of squamous cell carcinoma associated with sinonasal inverted papilloma.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemor | 2017 |
[A successful case of advanced nasal adenocarcinoma treated with tumor dormancy therapy with S -1 alone].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dis | 2008 |
[A case of advanced adenocarcinoma of the ethmoid sinus treated by chemoradiation with S-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Comb | 2009 |
Induction chemotherapy with docetaxel, cisplatin and S-1 followed by proton beam therapy concurrent with cisplatin in patients with T4b nasal and sinonasal malignancies.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Drug | 2012 |